trading halt, page-29

jevalent

You mentioned lifting of blind may have happened a couple of weeks ago. Cany you provide anymore on that for example the exact date.

_______________________________________________ This from the company in 2004......in actual fact, trading was not halted until 9th December, 2006.


"AOD9604 Obesity Drug Phase 2B Clinical Trial

Timetable for results We are pleased to advise that Metabolic’s Phase 2B trial on obesity drug AOD9604 remains on schedule with key dates as follows:

Last patient completed 12 week treatment period 17 September Last patient to attend one-month post-treatment follow-up visit by 20 October

Database to be cleaned and locked followed by lifting the double-blind by mid November Data analysed and reported to market by 30 November The double-blind will be lifted once all the data from the measurements up to the one-month post-treatment follow-up visit has been validated.

The independent contract bio-statistician will then analyse the data. Reporting format The Australian Stock Exchange has recently published a working draft of a Code of BestPractice for reporting by biotechnology companies. "